JAK2 and myeloproliferative neoplasm: Patients with JAK2 V617F-positive MPN are older in age (p = 0.003) and displayed high levels of haemoglobin (p < 0.01) and haematocrit (p < 0.01) and low levels of erythropoietin (p < 0.01).